1,580 results match your criteria: "Lentigo Maligna Melanoma"
Arch Dermatol Res
December 2024
Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 530 East 73rd Street, New York, NY, 10021, USA.
Melanoma of the lentigo maligna (LM) type is most commonly located on the head and neck region. This subtype of melanoma poses surgical challenges due to its location on anatomically sensitive areas and frequent presence of subclinical extension. To analyze the reconstruction patterns of LM patients undergoing margin-controlled surgery.
View Article and Find Full Text PDFBr J Dermatol
December 2024
Department of Population Health, QIMR Berghofer Medical Research Institute, Queensland, Australia.
Background: Understanding the factors influencing age at melanoma diagnosis by sex and anatomic site is crucial for developing effective prevention and early detection strategies. While previous research has highlighted sex-based differences in melanoma incidence by age and anatomic distribution, the underlying mechanisms remain unclear. We aimed to investigate sex-specific patterns in melanoma age at diagnosis across different anatomic sites and thickness categories, considering the potential influence of disease progression and detection rates.
View Article and Find Full Text PDFJAAD Int
February 2025
NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Background: Factors associated with nonadherence to guideline-recommended complete excision of suspicious cutaneous lesions are unclear.
Objective: The purpose of this study was to analyze patient, melanoma, and clinician factors associated with initial diagnostic biopsy type and determine whether unwarranted variation from guidelines occurred.
Methods: This population-based, cohort study involved the analysis of data from questionnaires completed by clinicians who managed patients with newly diagnosed, histopathologically confirmed primary invasive cutaneous melanomas reported to the New South Wales Cancer Registry between 2006 and 2007.
Dermatol Pract Concept
October 2024
Dermatology Service, Miguel Servet University Hospital, IIS Aragón, Zaragoza, Spain.
J Am Acad Dermatol
December 2024
Division of Dermatology, Dell Medical School at the University of Texas, Austin, Texas, USA.
Background: Lentigo maligna (LM), a type of melanoma in situ (MIS), usually develops on sun-damaged skin in the elderly. If left untreated, it may advance to the point of dermal invasion, developing into lentigo maligna melanoma (LMM). While surgeons have achieved robust clinical outcomes for LM treated with Mohs micrographic surgery (MMS), performing this treatment for LMM remains controversial and is not standard amongst all Mohs surgeons.
View Article and Find Full Text PDFDermatol Surg
December 2024
Department of Oral and Maxillofacial Surgery, University Hospital of Saint-Etienne, France.
Diagnostics (Basel)
November 2024
Ophthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.
Lentigo maligna (LM) often poses a diagnostic challenge due to its clinical and dermoscopic mimicry of benign lesions, leading to delayed diagnosis. Focal areas of reticular disruption have been described as one of the earliest dermoscopic signs observed. To describe a novel dermoscopic sign in LM, namely the presence of a parallel pigmented network.
View Article and Find Full Text PDFAustralas J Dermatol
November 2024
Mayne Academy of General Practice, Medical School, the University of Queensland, Brisbane, Queensland, Australia.
Melanomas on the dorsum of the hand are exceedingly rare, with limited documentation in medical literature. This report presents seven cases of dorsal hand and finger melanomas, encompassing patients from Australia, New Zealand and Turkey, predominantly women with a mean age of 53 years. The majority were invasive, with a mean Breslow thickness of 1.
View Article and Find Full Text PDFActas Dermosifiliogr
November 2024
Servicio de Dermatología, Hospital Universitario de Navarra, Pamplona, Navarra, Spain.
J Eur Acad Dermatol Venereol
November 2024
Department of Dermatology, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Melanoma of the lentigo maligna (LM) type and its invasive counterpart, lentigo maligna melanoma (LMM), occur in chronically sun-damaged skin and tend to have subclinical extension that makes presurgical margin mapping challenging. Reflectance confocal microscopy (RCM) is a non-invasive imaging modality that enables in vivo visualization of the skin at the cellular level, allowing for adequate estimation of LM/LMM margins. We aimed to perform a systematic review and meta-analysis evaluating RCM's performance compared with histopathology in margin mapping of LM/LMM.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
November 2024
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Lentigo maligna (LM) is a growing problem worldwide and the main type of melanoma in situ in some Caucasian populations. It presents as a spectrum from atypical intraepidermal melanocytic proliferation (AIMP) to invasive lentigo maligna melanoma (LMM). Accurate diagnosis and staging are crucial for determining appropriate management strategies.
View Article and Find Full Text PDFBioengineering (Basel)
October 2024
Dermatology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.
Clin Exp Dermatol
October 2024
Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Background: Melanoma in young adults significantly impacts the survival of this age group. There are limited studies that analyze melanoma characteristics in young patients. We aimed to describe the epidemiological, clinical, and histological characteristics of melanoma in young adults and their temporal trends over the last decades.
View Article and Find Full Text PDFClin Exp Dermatol
October 2024
Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK.
Cutaneous melanoma in situ (MIS), also known as 'stage 0 melanoma', is a collection of malignant melanocytes in the epidermis and epithelial adnexa, without evidence of microinvasion to the papillary dermis. Distinct histologic subtypes include lentigo maligna (LM), superficial spreading (SS) MIS and acral lentiginous (AL) MIS. LM is the most common subtype, usually diagnosed later in life (median age at diagnosis of 66-72 years) and associated with cumulative ultraviolet radiation exposure.
View Article and Find Full Text PDFJ Am Acad Dermatol
October 2024
Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA; Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address:
Lentigo Maligna (LM) arises on chronically-sun damaged skin and can have extensive subclinical spread, often in functionally and cosmetically challenging areas. This two-part continuing medical education (CME) series reviews LM. Part I reviews epidemiology, risk factors, clinical presentation, diagnostic tools, biopsy technique, and histopathology of LM.
View Article and Find Full Text PDFJ Am Acad Dermatol
October 2024
Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA; Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address:
Lentigo maligna (LM) is an increasingly common subtype of melanoma, presenting as a slow-growing tan-brown macule or patch with irregular borders arising on chronically solar-damaged skin. This two-part continuing medical education (CME) series provides an overview of LM. Part I reviews LM's epidemiology, risk factors, and clinical presentation.
View Article and Find Full Text PDFActas Dermosifiliogr
October 2024
Servicio de Dermatología, Hospital Universitario de Navarra, Pamplona, Navarra, España.
J Surg Oncol
October 2024
Department of Surgical Oncology, Corewell Health, Grand Rapids, Michigan, USA.
Melanoma affects over one million people in the United States. This review explores genetic mutations and markers of all seven subtypes. Current treatment options and prognosis of each subtype are also discussed.
View Article and Find Full Text PDFExp Dermatol
October 2024
Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Acta Derm Venereol
October 2024
Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Dermatology and Venereology, Gothenburg, Sweden.
Dermatol Surg
September 2024
Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
JAAD Case Rep
October 2024
Mountain West Dermatology, Grand Junction, Colorado.